Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Leaflet VEDIDA 200mg powder for solution for infusion
- Product code:
- W67738001
- Quantity:
- 1
- Indicated for:
- fungal infections
- Route of administration:
- infusion
- Substance:
- voriconazole (azole antifungal)
- ATC
- J02AC03 — Antiinfectives for systemic use | Antimycotics for systemic use | Antimycotics for systemic use | Triazole derivatives
Precautions:
Photosensitivity
Avoid excessive exposure to sunlight or UV radiation.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Pregnancy warning
Use during pregnancy only on medical advice.
Cardiac risk / QT prolongation / arrhythmias
This medicine may increase the risk of heart rhythm disturbances.
Voriconazole is an antifungal medication used to treat severe fungal infections, such as invasive aspergillosis, esophageal candidiasis, and other fungal infections caused by Candida or Fusarium species. It belongs to the triazole class and works by inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane, leading to fungal destruction.
Voriconazole is particularly indicated for immunocompromised patients, such as those with organ transplants, cancer, or other conditions that weaken the immune system. It is available in tablet form, oral suspension, or intravenous injection, and the dosage is adjusted based on the patient’s weight and the severity of the infection.
Common side effects include nausea, vomiting, abdominal pain, skin rashes, visual disturbances (such as blurred vision or light sensitivity), and elevated liver enzymes. Rarely, more serious reactions such as severe hepatotoxicity, allergic reactions, or cardiac arrhythmias may occur.
Treatment with voriconazole requires careful monitoring, including regular liver and kidney function tests. Patients should avoid prolonged sun exposure, as voriconazole can increase skin sensitivity to UV radiation. The medication should be taken as prescribed by a doctor, and dose adjustments should be made cautiously.
Voriconazole is particularly indicated for immunocompromised patients, such as those with organ transplants, cancer, or other conditions that weaken the immune system. It is available in tablet form, oral suspension, or intravenous injection, and the dosage is adjusted based on the patient’s weight and the severity of the infection.
Common side effects include nausea, vomiting, abdominal pain, skin rashes, visual disturbances (such as blurred vision or light sensitivity), and elevated liver enzymes. Rarely, more serious reactions such as severe hepatotoxicity, allergic reactions, or cardiac arrhythmias may occur.
Treatment with voriconazole requires careful monitoring, including regular liver and kidney function tests. Patients should avoid prolonged sun exposure, as voriconazole can increase skin sensitivity to UV radiation. The medication should be taken as prescribed by a doctor, and dose adjustments should be made cautiously.
General data about VEDIDA 200mg
- Substance:
- voriconazole
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W67738001
- Concentration:
- 200mg
- Pharmaceutical form:
- powder for solution for infusion
- Quantity:
- 1
- Product type:
- Generic medicine
- Price:
- 401.20 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for voriconazole
Concentrations available for voriconazole
- 200mg
- 40mg/ml
- 50mg
Compensation lists for VEDIDA 200mg Medochemie
G10 (C1) - Leukemias, lymphomas and bone marrow aplasia, tumors
- Price
- 401.20 RON
- Copayment
- 401.20 RON
- Patient
- 0.00 RON
GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)
- Price
- 401.20 RON
- Copayment
- 401.20 RON
- Patient
- 0.00 RON
NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment
- Price
- 401.20 RON
- Copayment
- 401.20 RON
- Patient
- 0.00 RON
NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant
- Price
- 401.20 RON
- Copayment
- 401.20 RON
- Patient
- 0.00 RON
NHP 9.5 (C2) - Pancreatic cell transplantation
- Price
- 401.20 RON
- Copayment
- 401.20 RON
- Patient
- 0.00 RON
NHP 9.7 (C2) - Outpatient treatment of transplant patients
- Price
- 401.20 RON
- Copayment
- 401.20 RON
- Patient
- 0.00 RON